carbamates has been researched along with Chronic Disease in 39 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "3 mg kg(-1), intraperitoneal [IP]) for 5 weeks corrected the reduction in body weight gain and sucrose intake induced by CMS." | 3.74 | Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. ( Arguello, O; Bortolato, M; Duranti, A; Fu, J; Kim, JH; Mangieri, RA; Mor, M; Piomelli, D; Tarzia, G; Tontini, A, 2007) |
| "Repaglinide is a novel insulin secretagogue developed in response to the need for a fast-acting, oral prandial glucose regulator for the treatment of type 2 (non-insulin-dependent) diabetes mellitus." | 2.69 | Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease. ( Christensen, MS; Hatorp, V; Haug-Pihale, G; Walther, KH, 2000) |
| "Cinacalcet hydrochloride was found to be cost effective only for those who cannot undergo parathyroidectomy." | 2.48 | [Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD]. ( Hamano, T, 2012) |
| "Orofacial cold hyperalgesia was induced in rats either by the administration of oxaliplatin or by infraorbital nerve chronic constrictive injury." | 1.42 | KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia. ( Abd-Elsayed, AA; Gu, JG; Ikeda, R; Jia, Z; Li, M; Ling, J; Zuo, X, 2015) |
| "At least, part of antiseizure effects of cannabinoid compounds is mediated through calcium (Ca(2+)) channels." | 1.38 | L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure. ( Ahmad-Molaei, L; Eslahkar, S; Mazar-Atabaki, A; Motiei-Langroudi, SM; Naderi, N; Ronaghi, A; Shirazi-zand, Z, 2012) |
| " Bioisosteric replacement of this biaryl moiety by arylpiperazine resulted in a soluble, orally bioavailable carbamate analogue providing identical activity in the acute model, comparable efficacy to OPC-67683 in a chronic infection model, favorable pharmacokinetic profiles across several species, and enhanced safety." | 1.38 | Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). ( Blaser, A; Denny, WA; Franzblau, SG; Kmentova, I; Ma, Z; Palmer, BD; Sutherland, HS; Thompson, AM; Wan, B; Wang, Y, 2012) |
| " We constructed physiologically based pharmacokinetic (PBPK) models for 3 nonrenally eliminated drugs (sildenafil, repaglinide, and telithromycin)." | 1.38 | Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation. ( Abernethy, DR; Arya, V; Atkinson, AJ; Berglund, EG; Grillo, JA; Huang, SM; Lesko, LJ; Pang, KS; Reynolds, KS; Song, P; Sugiyama, Y; Vieira, Mde L; Wu, TC; Zhang, L; Zhao, P; Zheng, JH, 2012) |
| "The use of lathyric toxins (BAPN) in low dosage (1 g/kg/day) for a period of 8 weeks caused in the rat simultaneous changes in the skin and aortic connective tissues." | 1.26 | [Chronic lathyrism. Protective effect of pyridinol carbamate on connective tissue lesions in the rat (author's transl)]. ( Bouissou, H; Foulquier, F; Julian, M; Pieraggi, MT; Vila, C, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (41.03) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 10 (25.64) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, DP | 1 |
| Liu, KJ | 1 |
| Kasper, G | 1 |
| Lin, Q | 1 |
| Hai, J | 1 |
| Griebel, G | 1 |
| Stemmelin, J | 1 |
| Lopez-Grancha, M | 1 |
| Fauchey, V | 1 |
| Slowinski, F | 1 |
| Pichat, P | 1 |
| Dargazanli, G | 1 |
| Abouabdellah, A | 1 |
| Cohen, C | 1 |
| Bergis, OE | 1 |
| Kawakubo, M | 1 |
| Eguchi, Y | 1 |
| Okada, M | 1 |
| Iwane, S | 1 |
| Oeda, S | 1 |
| Otsuka, T | 1 |
| Nakashita, S | 1 |
| Araki, N | 1 |
| Koga, A | 1 |
| Sarkar, R | 1 |
| Paul, R | 1 |
| Roy, D | 1 |
| Ghosh, R | 1 |
| Sau, TJ | 1 |
| Lahiri, G | 1 |
| Ruia, AV | 1 |
| Rathish, D | 1 |
| Senavirathna, I | 1 |
| Jayasumana, C | 1 |
| Agampodi, S | 1 |
| Siribaddana, S | 1 |
| Abd-Elsayed, AA | 1 |
| Ikeda, R | 1 |
| Jia, Z | 1 |
| Ling, J | 1 |
| Zuo, X | 1 |
| Li, M | 1 |
| Gu, JG | 1 |
| Naderi, N | 1 |
| Ahmad-Molaei, L | 1 |
| Mazar-Atabaki, A | 1 |
| Ronaghi, A | 1 |
| Shirazi-zand, Z | 1 |
| Motiei-Langroudi, SM | 1 |
| Eslahkar, S | 1 |
| Blaser, A | 1 |
| Palmer, BD | 1 |
| Sutherland, HS | 1 |
| Kmentova, I | 1 |
| Franzblau, SG | 1 |
| Wan, B | 1 |
| Wang, Y | 1 |
| Ma, Z | 1 |
| Thompson, AM | 1 |
| Denny, WA | 1 |
| Zhao, P | 1 |
| Vieira, Mde L | 1 |
| Grillo, JA | 1 |
| Song, P | 1 |
| Wu, TC | 1 |
| Zheng, JH | 1 |
| Arya, V | 1 |
| Berglund, EG | 1 |
| Atkinson, AJ | 1 |
| Sugiyama, Y | 1 |
| Pang, KS | 1 |
| Reynolds, KS | 1 |
| Abernethy, DR | 1 |
| Zhang, L | 2 |
| Lesko, LJ | 1 |
| Huang, SM | 1 |
| Chabwine, JN | 1 |
| Rossetti, AR | 1 |
| Hirt, L | 1 |
| Kuntzer, T | 1 |
| Schluep, M | 1 |
| Michel, P | 1 |
| Démonet, JF | 1 |
| du Pasquier, RA | 1 |
| Vingerhoets, FG | 1 |
| Joki, N | 1 |
| Iwasaki, M | 1 |
| Hamano, T | 1 |
| Martinez-Picado, J | 1 |
| Wrin, T | 1 |
| Frost, SD | 1 |
| Clotet, B | 1 |
| Ruiz, L | 1 |
| Brown, AJ | 1 |
| Petropoulos, CJ | 1 |
| Parkin, NT | 1 |
| Jayamanne, A | 1 |
| Greenwood, R | 1 |
| Mitchell, VA | 1 |
| Aslan, S | 1 |
| Piomelli, D | 2 |
| Vaughan, CW | 1 |
| Bortolato, M | 1 |
| Mangieri, RA | 1 |
| Fu, J | 1 |
| Kim, JH | 1 |
| Arguello, O | 1 |
| Duranti, A | 1 |
| Tontini, A | 1 |
| Mor, M | 1 |
| Tarzia, G | 1 |
| Grigor'ian, VA | 1 |
| Klantsa, NA | 1 |
| Prishliak, VD | 1 |
| Klantsa, PN | 1 |
| Hatorp, V | 1 |
| Walther, KH | 1 |
| Christensen, MS | 1 |
| Haug-Pihale, G | 1 |
| Ohayo-Mitoko, GJ | 1 |
| Kromhout, H | 1 |
| Simwa, JM | 1 |
| Boleij, JS | 1 |
| Heederik, D | 1 |
| Rizzardi, GP | 1 |
| Tambussi, G | 1 |
| Bart, PA | 1 |
| Chapuis, AG | 1 |
| Lazzarin, A | 1 |
| Pantaleo, G | 1 |
| Lácha, J | 1 |
| Rossmann, P | 1 |
| Lodererová, A | 1 |
| Havlíèková, J | 1 |
| Vítko, S | 1 |
| Kost, RG | 1 |
| Hurley, A | 1 |
| Vesanen, M | 1 |
| Talal, A | 1 |
| Furlan, S | 1 |
| Caldwell, P | 1 |
| Johnson, J | 1 |
| Smiley, L | 1 |
| Ho, D | 1 |
| Markowitz, M | 1 |
| Pampiglione, S | 1 |
| Pampiglione, G | 1 |
| Pagani, M | 1 |
| Rivasi, F | 1 |
| Jacobsohn, DA | 1 |
| Vogelsang, GB | 1 |
| Heydenreich, G | 1 |
| Larsen, PO | 1 |
| Bouissou, H | 1 |
| Pieraggi, MT | 1 |
| Julian, M | 1 |
| Foulquier, F | 1 |
| Vila, C | 1 |
| Fisanovich, TI | 1 |
| Tolstova, LG | 1 |
| Burkova, T | 1 |
| Baĭnova, A | 1 |
| Ivanova, L | 1 |
| Khaitov, RKh | 1 |
| Baimuradov, TB | 1 |
| Guliamov, A | 1 |
| Bagliani, A | 1 |
| Borri, P | 1 |
| Parravicini, R | 1 |
| Olefir, AI | 2 |
| Northridge, DB | 1 |
| Jardine, AG | 1 |
| Findlay, IN | 1 |
| Archibald, M | 1 |
| Dilly, SG | 1 |
| Dargie, HJ | 1 |
| Kissin, B | 1 |
| Gross, MM | 1 |
| Vieira, E | 1 |
| Meshel, E | 1 |
| Denber, HC | 1 |
| Kaneko, Y | 1 |
| Fukuzumi, H | 1 |
| Uemichi, A | 1 |
| Harada, S | 1 |
| Uehara, N | 1 |
| Sachsse, KR | 1 |
| Voss, G | 1 |
| Serafetinides, EA | 1 |
| Clark, ML | 1 |
| Kagan, IuS | 1 |
| Sasinovich, LM | 1 |
| Voronina, LIa | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Genetic, Epigenetic, Psychosocial, and Biological Determinants of Post-surgical Pain After Pectus or Spine Surgery[NCT04031716] | 600 participants (Anticipated) | Interventional | 2018-07-06 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carbamates and Chronic Disease
| Article | Year |
|---|---|
[Kidney and bone update : the 5-year history and future of CKD-MBD. Vascular calcification in CKD patients].
Topics: Bone Diseases, Metabolic; Calcium; Carbamates; Chelating Agents; Chronic Disease; Disease Progressio | 2012 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
Topics: Bone Diseases, Metabolic; Carbamates; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit An | 2012 |
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbamates; Chron | 2002 |
Toxicology of phosphamidon.
Topics: Acute Disease; Animals; Birds; Carbamates; Cattle; Chronic Disease; Dogs; Drug Compounding; Female; | 1971 |
6 trials available for carbamates and Chronic Disease
| Article | Year |
|---|---|
Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.
Topics: Adult; Blood Glucose; Blood Proteins; Caffeine; Carbamates; Chronic Disease; Humans; Hypoglycemic Ag | 2000 |
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
Topics: Adult; Anti-HIV Agents; Antigens, Fungal; Antigens, Viral; Antiretroviral Therapy, Highly Active; Ca | 2000 |
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Carbamates; CD4 L | 2001 |
Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Carbamates; Cardiac Output, Low; Chronic Disease; | 1990 |
The use of tybamate in psychotic patients. (A further double blind study).
Topics: Adult; Aged; Carbamates; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Place | 1968 |
Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
Topics: Adult; Carbamates; Chronic Disease; Female; Humans; Male; Phenothiazines; Placebos; Psychiatric Stat | 1971 |
29 other studies available for carbamates and Chronic Disease
| Article | Year |
|---|---|
Inhibition of SENP3 by URB597 ameliorates neurovascular unit dysfunction in rats with chronic cerebral hypoperfusion.
Topics: Animals; Apoptosis; Benzamides; Brain; Brain Ischemia; Carbamates; Chronic Disease; Disease Models, | 2017 |
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.
Topics: Acute Disease; Amides; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety Disorders; Arachidonic | 2018 |
Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of Life.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Chronic Disease; Drug Therapy, Combina | 2018 |
A Patient of Chronic Hepatitis C Complicated by Thalassemia Major and Chronic Osteomyelitis: A Therapeutic Challenge for a Clinician.
Topics: Adolescent; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Carbamates; Chronic Disease; Fema | 2018 |
A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka.
Topics: Acetylcholinesterase; Acute Disease; Adult; Atropine; Carbamates; Chronic Disease; Cross-Sectional S | 2019 |
KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
Topics: Action Potentials; Animals; Carbamates; Chronic Disease; Cold Temperature; Constriction; Disease Mod | 2015 |
L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.
Topics: Acute Disease; Animals; Anticonvulsants; Benzamides; Benzoxazines; Calcium Channels, L-Type; Cannabi | 2012 |
Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Topics: Acute Disease; Amides; Animals; Antitubercular Agents; Biological Availability; Biphenyl Compounds; | 2012 |
Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.
Topics: Area Under Curve; Carbamates; Chronic Disease; Computer Simulation; Drug Interactions; Humans; Ketol | 2012 |
[Neurology].
Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brai | 2012 |
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1.
Topics: Carbamates; Chronic Disease; Furans; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Human | 2005 |
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Chronic Disease; Disease Models, Animal; Enzyme In | 2006 |
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
Topics: Amidohydrolases; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Weight; Brain; C | 2007 |
[Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Topics: Adult; Aged; Carbamates; Cholesterol; Chronic Disease; Coronary Disease; Female; Humans; Hyperlipopr | 1981 |
Self reported symptoms and inhibition of acetylcholinesterase activity among Kenyan agricultural workers.
Topics: Acetylcholinesterase; Adult; Agricultural Workers' Diseases; Carbamates; Cholinesterase Inhibitors; | 2000 |
LF 08-0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model.
Topics: Animals; Aorta; Carbamates; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Graft R | 2000 |
[Persistent scalp infestation by Dermanyssus gallinae in an Emilian country-woman].
Topics: Acetic Acid; Aged; Animal Husbandry; Animals; Antiparasitic Agents; Beverages; Carbamates; Chamomile | 2001 |
[Occupational eczema in a rubber factory].
Topics: Balsams; Carbamates; Chromium; Chronic Disease; Denmark; Dermatitis, Occupational; Environmental Exp | 1977 |
[Chronic lathyrism. Protective effect of pyridinol carbamate on connective tissue lesions in the rat (author's transl)].
Topics: Aminopropionitrile; Animals; Carbamates; Chronic Disease; Connective Tissue; Fibroblasts; Lathyrism; | 1977 |
[Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Drug Evaluation; Endarteritis | 1979 |
[Pathologicoanatomic and enzymatic histochemical changes in the body of white rats with chronic, intermittent pirimor pesticide poisoning].
Topics: Animals; Brain; Carbamates; Chronic Disease; Dose-Response Relationship, Drug; Enzyme Activation; Fe | 1976 |
[Toxicity of antio for chickens].
Topics: Acute Disease; Animals; Antidotes; Carbamates; Chickens; Chronic Disease; Insecticides; Lethal Dose | 1975 |
[Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Clofibrate; Drug Combinations | 1975 |
[Study of the duration of after-effects of acute and chronic poisoning with chemical substances].
Topics: Acute Disease; Animals; Carbamates; Chronic Disease; Dinitrophenols; Immunity, Active; Immunity, Cel | 1976 |
[Effect of chronic intoxication with carbamine pesticides on the immunobiological reactivity and anti-infectious resistance].
Topics: Animals; Carbamates; Carbaryl; Chronic Disease; Immunity, Cellular; Insecticides; Rats; Staphylococc | 1973 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
[Clinical results of pyridinolcarbamate treatment of chronic Chagas' heart disease].
Topics: Carbamates; Chagas Disease; Chronic Disease; Evaluation Studies as Topic; Humans; Myocarditis; Pyrid | 1972 |
[Effect of anginin administration in chronic obstructive arterial diseases of the lower extremity, with special reference to the determination of therapeutic effect using the dye index curve].
Topics: Administration, Oral; Adult; Arteries; Carbamates; Chronic Disease; Dye Dilution Technique; Humans; | 1970 |
[Chronic action of some pesticides on the functional state of the liver].
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Proteins; Ca | 1970 |